trial · primary record
XmAb942
Ulcerative Colitis (UC)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2030-05 |
| Primary endpoint | Incidence, nature, and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs) of XmAb942 in healthy volunteers (Part A) |
| Registry ID | NCT06619990 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:17.068Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06619990
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.